Canadian Breast Cancer Symposium

June 19-20, 2025 — Hilton Downtown Toronto

Faculty

Conference Chairs

Christine Brezden-Masley

Christine Brezden-Masley
MD PhD FRCPC
Medical Oncologist, Mount Sinai Hospital
Medical Director, Cancer Program for Sinai Health
Director, Marvelle Koffler Breast Centre, Mount Sinai Hospital
Senior Clinical Scientist, Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital
Associate Professor, Department of Medicine, Division of Oncology
Temerty Faculty of Medicine, University of Toronto

Tulin Cil

Tulin Cil
MD MEd FRCSC
Gattuso Chair in Breast Surgical Oncology, University Health Network
Associate Professor, Department of Surgery, University of Toronto
Associate Member, Institute of Medical Science, University of Toronto
Staff Surgical Oncologist, Princess Margaret Cancer Centre

Committee

Jean-Francois Boileau MD MSc FRCSC
Surgical Oncologist, Jewish General Hospital Segal Cancer Centre
Associate Professor Surgery and Oncology, McGill University
Director JGH Breast Clinical Trials Group

Stephen Chia MD FRCPC
Professor of Medicine University of British Columbia
Medical Oncologist BC Cancer Vancouver Centre
Vancouver British Columbia
Staff Surgical Oncologist Princess Margaret Cancer Centre

MJ DeCoteau
Patient Group Advocate
Founder and Executive Director
Rethink Breast Cancer
Toronto Ontario

Katarzyna Jerzak MD MSc FRCPC
Assistant Professor Department of Medicine
Temerty Faculty of Medicine, University of Toronto
Medical Oncologist Sunnybrook Odette Cancer Centre
Associate Scientist Sunnybrook Research Institute

Anne Koch MD PhD FRCPC
Associate Professor Department of Radiation Oncology
University of Toronto
Lead Princess Margaret Breast Cancer Program
Radiation Oncologist and Clinician-Investigator Radiation Medicine Program
Princess Margaret Cancer Centre University Health Network

Nancy Nixon MD FRCPC
Assistant Professor University of Calgary
Medical Oncologist Breast Tumour Group
Southern Alberta Tumour Team Lead
Tom Baker Cancer Centre
Calgary Alberta

May Lynn Quan MD MSc FRCSC
Professor of Surgery Oncology & Community Health Sciences University of Calgary
Medical Director Calgary Breast Health Program
Scientific Director Strategies for Precision Health in Breast Cancer (SPHERE)
Calgary Alberta

Amanda Roberts MD MPH FRCSC
Breast Surgical Oncologist, Sunnybrook Health Sciences Centre
Assistant Professor, Department of Surgery
Division of General Surgery
Temerty Faculty of Medicine University of Toronto
Affiliate Scientist, Sunnybrook Research Institute
Co-Site Lead, Louise Temerty Breast Cancer Centre, Sunnybrook Health Sciences Centre
Co-Program Director, Breast Surgical Oncology Fellowship, University of Toronto

Melinda Wu MD MScCH CCFP FCFP
Assistant Professor Department of Family and Community Medicine
Temerty Faculty of Medicine University of Toronto
General Practitioner in Oncology Breast Centre WCH PMH
Clinical Education Lead Gilgan Centre for Women’s Cancers
Program Co-Director WCH Family Medicine Post-Grad Medical Education
Family Physician Women’s College Hospital


Faculty Disclosure

It is the policy of the University of Toronto, Temerty Faculty of Medicine, Continuing Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs.

Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains but is not limited to relationships within the last FIVE (5) years with not-for-profit organizations, pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.

The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts.

It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.